229 related articles for article (PubMed ID: 11217142)
1. Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects.
Sechi LA; De Marchi S
J Investig Med; 2001 Jan; 49(1):12-20. PubMed ID: 11217142
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein (a), haemostatic variables and cardiovascular damage in hypertensive patients.
Sechi LA; Catena C; Casaccio D; Zingaro L
J Hypertens; 2000 Jun; 18(6):709-16. PubMed ID: 10872555
[TBL] [Abstract][Full Text] [Related]
3. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.
Sechi LA; Kronenberg F; De Carli S; Falleti E; Zingaro L; Catena C; Utermann G; Bartoli E
JAMA; 1997 Jun; 277(21):1689-95. PubMed ID: 9169895
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
[TBL] [Abstract][Full Text] [Related]
5. Relationship of early carotid artery disease with lipoprotein (a), apolipoprotein B, and fibrinogen in asymptomatic essential hypertensive patients and normotensive subjects.
Rossl A; Baldo-Enzi G; Ganzaroli C; Coscetti G; Calabro A; Baiocchi MR; Maiolino G; Pessina AC; Rossi GP
J Investig Med; 2001 Nov; 49(6):505-13. PubMed ID: 11730086
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance.
Catena C; Zingaro L; Casaccio D; Sechi LA
Am J Med; 2000 Nov; 109(7):556-61. PubMed ID: 11063957
[TBL] [Abstract][Full Text] [Related]
7. Low order correlations of lipoprotein(a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients.
Donders SH; Lustermans FA; van Wersch JW
Blood Coagul Fibrinolysis; 1992 Jun; 3(3):249-56. PubMed ID: 1386533
[TBL] [Abstract][Full Text] [Related]
8. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
Glueck CJ; Glueck HI; Tracy T; Speirs J; McCray C; Stroop D
Metabolism; 1993 Feb; 42(2):236-46. PubMed ID: 8474322
[TBL] [Abstract][Full Text] [Related]
9. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension.
Sechi LA; Zingaro L; Catena C; Casaccio D; De Marchi S
Hypertension; 2000 Dec; 36(6):978-85. PubMed ID: 11116111
[TBL] [Abstract][Full Text] [Related]
10. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients.
Donders SH; Lustermans FA; Van Wersch JW
Scand J Clin Lab Invest; 1993 Apr; 53(2):179-86. PubMed ID: 8469917
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
[TBL] [Abstract][Full Text] [Related]
13. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
Głowińska B; Urban M; Koput A; Galar M
Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
[TBL] [Abstract][Full Text] [Related]
14. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG
Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937
[TBL] [Abstract][Full Text] [Related]
15. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
Lip PL; Blann AD; Jones AF; Lip GY
Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
[TBL] [Abstract][Full Text] [Related]
18. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
20. The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
Sarafidis PA; Lasaridis AN; Nilsson PM; Mouslech TF; Hitoglou-Makedou AD; Stafylas PC; Kazakos KA; Yovos JG; Tourkantonis AA
Metabolism; 2005 Sep; 54(9):1236-42. PubMed ID: 16125536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
